September 2010 Issue of MMM
Finally, some good news--salaries are back! At least, according to the 24th annual MM&M Career & Salary Survey.
Following last year's unprecedented decreases, average salaries have bounced back to 2008 levels. Is the storm finally passing? James Chase reports on the key findings ...
Employees may be an agency's number-one asset, but priorities can change when profits are at stake. As Tanya Lewis finds, smart agencies are not scaling ...
Every job is a journey, and pharma marketing is no exception. Here are eight who are chugging along to fulfilling careers, both professionally and personally
Back in July, an esteemed panel of 41 expert healthcare executives, spanning the fields of marketing, communications and media, came together to review and score ...
Mike Huckman spent 27 years in television--the last eight of them covering the pharma beat for CNBC--before joining healthcare PR powerhouse MS&L as SVP, director ...
With increasing FDA regulations on DTC advertising, in-flight campaign optimization remains a challenge for pharma marketers who must take corrective action when a campaign does ...
As a fan, prescriber, and consumer of Pfizer's blockbuster cholesterol-lowering statin drug Lipitor, I've long joked that in addition to increasing exercise and improving diet, ...
It was lunchtime on day two of ExL's pharma public relations conference at Pfizer headquarters, and the host, Pfizer PR chief Ray Kerins, took the ...
Beginning in 2011, GlaxoSmithKline will reward its sales reps for the relationships they forge with doctors, instead of the amount of drugs they sell.
California-based Cypress Bioscience ended its co-promotion agreement with Forest Laboratories on Savella (milnacipran), a fibromyalgia drug approved in January 2009.
Featuring news about Eli Lilly; Challenger, Gray and Christmas; and SmithKline Beecham
Med Ed Report
At a July FDA advisory hearing on ways to increase the safety of extended-release and long-acting opioid drugs, the agency opened the door to using ...
A measure to repeal Massachusetts' pharma gift ban failed to make it into a final economic stimulus bill but may yet resurface.
An analysis of studies registered on ClinicalTrials.gov showed those funded by industry were more apt to show positive outcomes but less apt to be published ...
Featuring news about Genentech, Harvard Medical School, University of Minnesota, KnowledgePoint360 and the National Commission for Certification of CME Professionals
Thieme Publishers will distribute UK-based Manson Publishing titles in the Americas and India, a portfolio that includes close to 100 medical and veterinary titles.
The New England Journal of Medicine (NEJM) launched a new website in July, including an archive of past issues dating back to 1812.
Featuring news about Elsevier, Wolters Kluwer Health and GlaxoSmithKline
With journal spend taking a dive, many agencies have jettisoned internal media buyers, outsourcing to the big network shops among others. What do you see ...
A Facebook Share widget found on Novartis' Tasigna (nilotinib) website provoked a DDMAC untitled letter, the fourth DDMAC communiqué Novartis has received this year.
WEGO Health is sponsoring all health networks at social networking platform Ning.com, enabling a million Ning network users to go on posting free of charge ...
Featuring news about WebMD, Spina Bifida, VitaPath Genetics and Elsevier's Skin & Allergy News Digital Network
Dey Pharmaceuticals has delivered a terrific integrated DTC campaign for its EpiPen product. By using disease-state or "unbranded" advertising on television, on the web and ...
Merck teamed up with the Asthma and Allergy Foundation of America (AAFA), and former Miss Universe Dayanara Torres, for an asthma education website targeting Spanish-speakers.
The FDA demanded that Jazz Pharmaceuticals halt dissemination of a patient brochure for Luvox CR and run corrective messages to counter inflated benefit claims and ...
Seeking on rival Johnson & Johnson's woes with a giveaway of its new Triaminic OTC children's acetaminophen, Novartis said it would distribute 250,000 bottles of ...
The economy might be retrenching and consumers souring, but consumer marketers are feeling more confident, according to a survey by Cegedim Dendrite which found that ...
Featuring news about the American Cancer Society Cancer Action Network, Takeda, GlaxoSmithKline, the Amgen Foundation and Ashoka's Changemakers
Citing decreased demand, pharmaceutical promotional support firm PDI said it planned to exit its TVG Marketing Research & Consulting business unit last month.
Market-research firm ImpactRx has launched an iPhone application it says provides pharmaceutical companies insights into drug therapy promotion.
Like many Razorfish Health clients, the Alzheimer's Association Delaware Valley Chapter knew they needed a social media presence but needed some handholding to get there.
Grey Healthcare Group (ghg) is making a play for the animal health marketing space with its acquisition of Geoff Howe Marketing Communications.
Featuring news about Ignite Health, Tonic Life Communication, Spectrum, Interpublic and Delaney Lund Knox Warren
Over 30 years ago a gregarious Congressman from Louisiana gave me and others some off-the-record advice on how to succeed on Capitol Hill.
As it wrestles with the drug's safety issues, including public disagreements about them within its own ranks, FDA referred in July to the HHS Office ...
FDA should have acted sooner to ban unapproved DTC genetic tests, the agency's medical devices director, Jeffrey Shuren told a House hearing after listening to ...
In response to seismic forces that are buffeting the US medical marketplace, most pharma companies are phasing in new commercial models that, among other things, ...
They can in more ways than you might imagine, especially if they conjure the real purpose of PR and not the "spin" that contributed to ...
The number of pharma sales reps who wait for doctors and never see them is quickly growing.
Click here to learn about the Agency Issue.
- When it comes to professional ads, print makes its comeback
- Amgen takes issue with yet-to-be published multiple-myeloma drug report
- How Watson for Oncology is advancing cancer care
- Creative partners should push pharma clients to tell better stories
- Retaining talent: How pharma can compete with Google